China’s market crash spooks investors

Spooked investors unloaded their holdings sending the markets plummeting with the Dow crashing 365 points to 16,540. Nasdaq slumped 133 points to 4,702.

On the upside

Biocept (Nasdaq: BIOC) launched its prostate cancer detection and monitoring test that uses a patient’s blood.

uniQure (Nasdaq: QURE) reported positive preliminary results from an ongoing PhaseI/II clinical trial of AMT-060 in adult hemophilia B patients.

J.C. Penney (NYSE: JCP) reported a strong 3.9% increase in same store sales during the holiday months of November and December.

On the downside

TetraLogic Pharmaceuticals (Nasdaq: TLOG) reported disappointing results from a Phase 2 study of birinapant to treat myelodysplastic syndromes.

Caladrius Biosciences (Nasdaq: CLBS) discontinued a Phase 3 study of CLBS20 to treat metastatic melanoma and will direct more resources to its cell therapy development subsidiary PCT.

Shares of California Resources (NYSE: CRC) dropped as crude oil prices continued to fall.

In the broad market, declining issues outpaced advancers by a margin of nearly 7 to 1 on the NYSE and by 6 to 1 on Nasdaq. The broader S&P 500 sank 42 points to 1,948. Bitcoin soared $21 to $452.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.